Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.5%

81 terminated/withdrawn out of 853 trials

Success Rate

83.7%

-2.8% vs industry average

Late-Stage Pipeline

9%

73 trials in Phase 3/4

Results Transparency

38%

159 of 417 completed trials have results

Key Signals

127 recruiting159 with results47 terminated34 withdrawn

Enrollment Performance

Analytics

N/A
408(59.9%)
Phase 2
92(13.5%)
Phase 1
72(10.6%)
Phase 3
37(5.4%)
Phase 4
36(5.3%)
Early Phase 1
36(5.3%)
681Total
N/A(408)
Phase 2(92)
Phase 1(72)
Phase 3(37)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (853)

Showing 20 of 853 trials
NCT07441889Phase 1Recruiting

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Role: lead

NCT06318975Not ApplicableRecruiting

Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use

Role: lead

NCT05605301Phase 2Completed

Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

Role: lead

NCT06869343Not ApplicableRecruiting

Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture

Role: lead

NCT07535541Not ApplicableRecruiting

A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)

Role: lead

NCT05280639Not ApplicableRecruiting

Simplified Post Op Rehabilitation for Ankle and Pilon Fractures

Role: lead

NCT01905865Completed

The Role of Uncertainty in Coping: The Experience of Parents of Children With Undiagnosed Medical Conditions

Role: collaborator

NCT05294302Not ApplicableRecruiting

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Role: collaborator

NCT05424003Phase 2Recruiting

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

Role: lead

NCT05580978Not ApplicableCompleted

CGM Plus GEM in Prediabetes

Role: collaborator

NCT07131384Not ApplicableRecruiting

Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes

Role: lead

NCT00903591Active Not Recruiting

Study of Radiation Exposure and Bilateral Breast Cancer

Role: collaborator

NCT05505604Not ApplicableActive Not Recruiting

PENG vs FICB for Hip Fracture in ED Patients

Role: lead

NCT05523440Phase 2Terminated

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Role: collaborator

NCT07615842Phase 1Not Yet Recruiting

Assessing the Impact of Unnecessary Antibiotic Treatment on the Development of Appropriate Adaptive Immune Responses in Malnourished Bangladeshi Infants

Role: lead

NCT07332325Phase 3Not Yet Recruiting

STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis

Role: lead

NCT05857852Not ApplicableCompleted

Low-Intensity Focused Ultrasound for Cocaine Use Disorder

Role: lead

NCT03969238Completed

Utilizing Helpline for Opioid Dependence Treatment

Role: lead

NCT07094711Phase 2Recruiting

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)

Role: lead

NCT06802224Phase 4Recruiting

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Role: collaborator